Development News Edition
Give Feedback
VisionRI - Urban Development

Reuters Health News Summary

Updated: 17-04-2019 18:27 IST
Reuters Health News Summary

Following is a summary of current health news briefs. South Africa's Tiger Brands to fight listeria class action

South Africa's leading food producer Tiger Brands said on Wednesday it will fight a class action lawsuit over its role in the world's largest ever listeria outbreak. The listeriosis outbreak, the infection caused by the bacteria, killed more than 200 people in South Africa last year and was traced back to a factory run by Tiger Brands-owned Enterprise Foods. Child abuse, recurrent depression linked to similar changes in brain

Abuse during childhood may cause physical changes to the human brain that in turn may render adults more vulnerable to depression, research suggests. In their study of people with major depressive disorder, two separate aspects of patients' history were both linked with alterations in brain structure: childhood maltreatment, and more severe and recurrent depression. China urges large pig farms to test for African swine fever

China will allow large-scale pig farms and breeding farms to test for African swine fever in a bid to help early detection of the disease, overturning an earlier prohibition on commercial firms carrying out their own testing. The agriculture ministry has asked local husbandry bureaus to encourage large farms to obtain testing kits for the deadly virus that has swept through the country, the Ministry of Agriculture and Rural Affairs said on its website on Tuesday. Switzerland to monitor potential health risks posed by 5G networks

Switzerland will introduce a monitoring system to assuage concerns about the potential health impact of fifth-generation (5G) mobile frequency emissions and smooth the cutting-edge technology's rollout, the government said on Wednesday. The cabinet agreed to have the federal environmental agency measure levels of so-called non-iodising radiation, assess the risks and regularly inform the public about its findings. Recordati to seek Canadian approval for kidney disease drug

Italy's Recordati said on Tuesday it plans to seek Canadian approval for its drug Cystagon, which treats a rare kidney disease, in a potential blow to Horizon Pharma,, which makes the only drug approved for treatment in Canada. Cystagon and Horizon's drug Procysbi use the same active ingredient to treat nephropathic cystinosis, a genetic disorder that can cause fatal kidney damage. Only about 100 people in Canada have the disease, but at list prices Procysbi costs C$325,000 ($243,336.33) per year, according to Canadian regulators. Ebola is real, Congo president tells skeptical population

Congolese President Felix Tshisekedi on Tuesday implored people in areas hit by the nation's worst-ever Ebola outbreak to accept the disease is real and trust health workers. Mistrust of first responders and widespread misinformation propagated by some community leaders has led many in affected areas of eastern Democratic Republic of Congo to refuse vaccinations. Instead, they turn to traditional healers, whose clinics have contributed to the hemorrhagic fever's spread. Ebola survivors comfort sick and frightened in Congo outbreak

Wearing a disposable gown and gloves for protection, Jeanine Masika cradles a 2-year-old Ebola patient and offers the listless toddler teaspoons of brown soup. Most health care workers need a surgical mask, goggles, hooded coveralls, an apron, rubber boots and two pairs of gloves to avoid catching the virus that typically kills around half those it infects. FDA orders transvaginal surgical mesh pulled from market

The U.S. Food and Drug Administration on Tuesday ordered makers of transvaginal surgical mesh implants to immediately stop their sale and distribution in the United States, the latest action by the agency to tackle safety issues related to the devices. The FDA said Boston Scientific Corp and Coloplast A/S did not demonstrate a reasonable assurance of safety and effectiveness of these devices in their premarket applications. The companies will have 10 days to submit their plan to withdraw these products from the market, the FDA said in a statement U.S. health officials probe multi-state Salmonella outbreak

U.S. federal health officials said on Tuesday an investigation is underway over a multi-state outbreak of Salmonella Newport infections linked to frozen ground tuna, which were imported into the United States by seafood retailer Jensen Tuna. No deaths were reported so far, but seven people have been hospitalized, the U.S. Food and Drug Administration (FDA) said in a statement U.S. measles cases surge nearly 20 percent in early April, CDC says

The number of confirmed cases of measles in the United States this year jumped by nearly 20 percent in the week ended April 11, in the country's second-worst outbreak in nearly two decades, federal health officials reported on Monday. As of April 11, the U.S. Centers for Disease Control and Prevention (CDC) recorded 555 cases of the disease since the beginning of the year, up from 465 cases confirmed by April 4. The cases were found in 20 states spanning the country.